Eyenovia Reports Third Quarter 2019 Financial Results

Go back to Eyenovia Reports Third Quarter 2019 Financial Results

Eyenovia Inc (EYEN) Tops Q3 EPS by 5c

November 13, 2019 4:23 PM EST

Eyenovia Inc (NASDAQ: EYEN) reported Q3 EPS of ($0.29), $0.05 better than the analyst estimate of ($0.34).

Third Quarter 2019 and Recent Business Highlights

Advanced MicroLine for the improvement in near vision in patients with presbyopia towards Phase III development;Deferred development activities for the MicroProst (glaucoma and ocular hypertension) and MicroTears (red eye and itch relief/lubrication) programs;Presented data from the MicroStat Phase III MIST-1 and MIST-2 studies for pharmacologic mydriasis at AAOpt; andSuccessfully... More